Effect of inhaled corticosteroids on the hypothalamic-pituitary-adrenal axis and growth in children

2000 ◽  
Vol 137 (4) ◽  
pp. 450-454 ◽  
Author(s):  
Lenore S. Levine ◽  
Bruce A. Boston
PEDIATRICS ◽  
1988 ◽  
Vol 81 (3) ◽  
pp. 452-455
Author(s):  
Gregory A. Hollman ◽  
David B. Allen

Inhaled corticosteroids have become an important therapeutic option in the treatment of childhood asthma. The preparations currently available for pediatric use (beclomethasone dipropionate and triamcinolone acetonide) do not, in general, cause significant hypothalamic-pituitary-adrenal axis suppression and physical signs of glucocorticoid excess have not been described with their use. We report an 8-year-old girl with asthma in whom obesity, hirsutism, and growth retardation developed during treatment with inhaled triamcinolone acetonide alone. Laboratory studies showed suppression of endogenous cortisol production but did not demonstrate suppression of the hypothalamic-pituitary-adrenal axis. Cessation of inhaled triamcinolone acetonide therapy resulted in resolution of obesity and hirsutism, resumption of normal growth, and a return to normal of serum cortisol levels and urinary 17-hydroxycorticosteroid excretion. Careful monitoring of growth velocity and (if clinically indicated) morning serum cortisol levels in asthmatic children using inhaled corticorsteroids will detect the rare instance of glucocorticoid excess resulting from systemic absorption of these drugs.


2012 ◽  
Vol 44 (3) ◽  
pp. 314 ◽  
Author(s):  
Negin Rashidi ◽  
Nader Rezaie ◽  
Ramin Heshmat ◽  
KeivanGohari Moghaddam ◽  
HamidrezaAghaei Meybodi ◽  
...  

2012 ◽  
Vol 19 (2) ◽  
pp. 88-95 ◽  
Author(s):  
Lemonia Tsartsali ◽  
Marios Papadopoulos ◽  
Evagelia Lagona ◽  
Anastasios Papadimitriou ◽  
Christina Kanaka-Gantenbein ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document